Coherus Oncology, Inc. (CHRS)
1.41
-0.05
(-3.42%)
USD |
NASDAQ |
Aug 28, 16:00
1.40
-0.01
(-0.71%)
After-Hours: 20:00
Coherus Oncology Max Drawdown (5Y) : 97.03% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 97.03% |
| June 30, 2026 | 97.03% |
| May 31, 2026 | 97.03% |
| April 30, 2026 | 97.03% |
| March 31, 2026 | 97.03% |
| February 28, 2026 | 97.03% |
| January 31, 2026 | 97.03% |
| December 31, 2025 | 97.03% |
| November 30, 2025 | 97.03% |
| October 31, 2025 | 97.03% |
| September 30, 2025 | 97.03% |
| August 31, 2025 | 97.03% |
| July 31, 2025 | 97.03% |
| June 30, 2025 | 97.03% |
| May 31, 2025 | 97.03% |
| April 30, 2025 | 97.03% |
| March 31, 2025 | 97.03% |
| February 28, 2025 | 97.03% |
| January 31, 2025 | 97.03% |
| December 31, 2024 | 97.03% |
| November 30, 2024 | 97.03% |
| October 31, 2024 | 96.80% |
| September 30, 2024 | 95.60% |
| August 31, 2024 | 94.50% |
| July 31, 2024 | 94.36% |
| Date | Value |
|---|---|
| June 30, 2024 | 93.24% |
| May 31, 2024 | 93.20% |
| April 30, 2024 | 93.20% |
| March 31, 2024 | 93.20% |
| February 29, 2024 | 93.20% |
| January 31, 2024 | 93.20% |
| December 31, 2023 | 93.20% |
| November 30, 2023 | 93.20% |
| October 31, 2023 | 88.70% |
| September 30, 2023 | 84.00% |
| August 31, 2023 | 83.78% |
| July 31, 2023 | 83.78% |
| June 30, 2023 | 83.78% |
| May 31, 2023 | 82.50% |
| April 30, 2023 | 77.63% |
| March 31, 2023 | 77.63% |
| February 28, 2023 | 77.63% |
| January 31, 2023 | 77.63% |
| December 31, 2022 | 77.63% |
| November 30, 2022 | 77.63% |
| October 31, 2022 | 77.71% |
| September 30, 2022 | 77.71% |
| August 31, 2022 | 77.71% |
| July 31, 2022 | 77.71% |
| June 30, 2022 | 77.71% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Enanta Pharmaceuticals, Inc. | 95.62% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Anika Therapeutics, Inc. | 83.15% |
| Savara, Inc. | 97.41% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -48.56 |
| Beta (5Y) | 0.9760 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 86.70% |
| Historical Sharpe Ratio (5Y) | -0.4565 |
| Historical Sortino (5Y) | -1.051 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.93% |